TapImmune Inc. (TPIV.OB) is “One to Watch”
QualityStocks (November 9th, 2009) Writes:
TapImmune Inc. is a biotechnology company headquartered in Bellevue, Washington. They specialize in the development of immunotherapeutic vaccines for cancer and infectious diseases. Their core business focus is on emerging technologies based on cellular immunology and genetic understanding of the cause and potential novel treatments of disease.
TapImmune Inc.’s lead product is the TAP vaccine. It performs a key step in moving characteristic markers called antigens to the surfaces of cells. Without TAP, there are no cancer markers. Therefore, the immune system fails to spot the rogue cells and the cancerous cells can grow undetected. In addition, the TAP molecule works as an adjuvant (accelerant) to enhance targeted vaccines against infectious diseases.
The Company is developing AdhTAP for the commencement of toxicology studies leading to the initiation of Phase I clinical trials. The expectation is that the global vaccine market will grow from $13 billion in 2007 to $21 billion
...AdhTAP, Bellevue, Biopharmaceuticals, Biotechnology, cancer, Cancer Treatment, Cancers, Crucell N.V., human genome;, Immunotherapy, Infectious Disease, Infectious Diseases, Investing Lessons, Melanoma, production technology;, Small & Micro Cap, TAP technology, TapImmune Inc., USD, vaccine products, Vaccines, Washington


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)



